Asia · Bolsa y Finanzas · SCMP Business

Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca

Publicado por SCMP Business · Hong Kong hace 2 h

Hong Kong can attract more global biotech investments if the city builds up a new healthcare financial model, according to AstraZeneca, a Cambridge-based multinational…

Leer el artículo completo en SCMP Business Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.scmp.com)

Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca

También te puede interesar

Younger researchers studying pressing labour issues get more support from NTUC

Capital SFB Q2 Update: Deposits rise 16%, advances up 23%; Gross NPA improves

Gold price future roadmap: Why led to 6% yellow metal fall in Sept 2026? Will Diwali help bounce back? Experts view

At 52-week lows: RIL, ONGC, M&M, Airtel, PB Fintech, 69 other BSE500 stocks

Jacqueline Loh to step down as MAS deputy MD in senior leadership reshuffle

ShopeePay CEO on BNPL: why relying on late fees will fail

Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca

Compartir

También te puede interesar

Younger researchers studying pressing labour issues get more support from NTUC

Capital SFB Q2 Update: Deposits rise 16%, advances up 23%; Gross NPA improves

Gold price future roadmap: Why led to 6% yellow metal fall in Sept 2026? Will Diwali help bounce back? Experts view

At 52-week lows: RIL, ONGC, M&M, Airtel, PB Fintech, 69 other BSE500 stocks

Jacqueline Loh to step down as MAS deputy MD in senior leadership reshuffle

ShopeePay CEO on BNPL: why relying on late fees will fail